Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative TherapySergio Giralt, Richard E. Champlin, Miloslav Beran et al.|Blood|1997Cited by 1.2k
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.Issa F. Khouri, Richard E. Champlin, Michael J. Keating et al.|Journal of Clinical Oncology|1998Cited by 927
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationSergio Giralt, Richard E. Champlin, Peter F. Thall et al.|Blood|2001Cited by 570
Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationSergio Giralt, Richard E. Champlin, Peter F. Thall et al.|Blood|2001Cited by 516
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donorsMichael A. Pulsipher, Thomas R. Spitzer, Brent R. Logan et al.|Haematologica|2018Cited by 22